Skip to Main Content

Author Details

Gray R Anderson
Duke University
2014
15
11
Antoine Forget (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36711936MCB-613 exploits a collateral sensitivity in drug resistant <i>EGFR</i>-mutant non-small cell lung cancer through covalent inhibition of KEAP1.bioRxiv2023
34215753Cellphone enabled point-of-care assessment of breast tumor cytology and molecular HER2 expression from fine-needle aspirates.NPJ Breast Cancer2021
34535683Author Correction: Cellphone enabled point-of-care assessment of breast tumor cytology and molecular HER2 expression from fine-needle aspirates.NPJ Breast Cancer2021
32203462Using antagonistic pleiotropy to design a chemotherapy-induced evolutionary trap to target drug resistance in cancer.Nat Genet2020
32005716Inhibition of BCL2 Family Members Increases the Efficacy of Copper Chelation in BRAF<sup>V600E</sup>-Driven Melanoma.Cancer Res2020
32238925CRISPR screens in cancer spheroids identify 3D growth-specific vulnerabilities.Nature2020
31517048Genomically informed small-molecule drugs overcome resistance to a sustained-release formulation of an engineered death receptor agonist in patient-derived tumor models.Sci Adv2019
29700304Dysregulation of mitochondrial dynamics proteins are a targetable feature of human tumors.Nat Commun2018
30158527Systematic mapping of BCL-2 gene dependencies in cancer reveals molecular determinants of BH3 mimetic sensitivity.Nat Commun2018
28746882A Landscape of Therapeutic Cooperativity in KRAS Mutant Cancers Reveals Principles for Controlling Tumor Evolution.Cell Rep2017
28593995Codon bias imposes a targetable limitation on KRAS-driven therapeutic resistance.Nat Commun2017
27050525ERRα-Regulated Lactate Metabolism Contributes to Resistance to Targeted Therapies in Breast Cancer.Cell Rep2016
27974663PIK3CA mutations enable targeting of a breast tumor dependency through mTOR-mediated MCL-1 translation.Sci Transl Med2016
27283158Targeting MCL-1/BCL-XL Forestalls the Acquisition of Resistance to ABT-199 in Acute Myeloid Leukemia.Sci Rep2016
25538079Systematic identification of signaling pathways with potential to confer anticancer drug resistance.Sci Signal2014
  • 1 - 15 of 15

Recommended Authors

Sahil Seth
The University of Texas MD Anderson Cancer Center
Career Start Year 2014
Number of shared co-authors 1
Andrew Goodspeed
University of Colorado Denver | Anschutz Medical Campus
Career Start Year 2013
Number of shared co-authors 0
Victor Olivas
University of California san francisco
Career Start Year 2012
Number of shared co-authors 0
Frederick S Vizeacoumar
College of Medicine, University of Saskatchewan
Career Start Year 2010
Number of shared co-authors 0
Amanda L Christie
Dana-Farber Cancer Institute
Career Start Year 2010
Number of shared co-authors 1
Aleksandra M Michalowski
Center for Cancer Research, National Cancer Institute
Career Start Year 2010
Number of shared co-authors 0
John Paul Shen
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 0
Martin L Sos
University of Cologne, Faculty of Medicine and University Hospital Cologne
Career Start Year 2005
Number of shared co-authors 1
Jesse S Boehm
Broad Institute of Harvard and MIT
Career Start Year 2004
Number of shared co-authors 3
David W Cescon
Princess Margaret Cancer Centre
Career Start Year 2003
Number of shared co-authors 2
Aik Choon Tan
Huntsman Cancer Institute, The University of Utah
Career Start Year 2003
Number of shared co-authors 1
Xiaohu Zhang
National Center for Advancing Translational Sciences
Career Start Year 2003
Number of shared co-authors 0
Jonathan R Dry
Present Address: Tempus Labs Inc.
Career Start Year 2003
Number of shared co-authors 0
Elena Ivanova
Dana-Farber Cancer Institute
Career Start Year 2003
Number of shared co-authors 0
Justin Cidado
Oncology R&D
Career Start Year 2003
Number of shared co-authors 0
Trever G Bivona
University of California san francisco
Career Start Year 2002
Number of shared co-authors 5
Nikhil Wagle
Dana-Farber Cancer Institute
Career Start Year 2000
Number of shared co-authors 1
Andrea Bertotti
Candiolo Cancer Institute - FPO IRCCS
Career Start Year 2000
Number of shared co-authors 2
Eric A Collisson
University of California san francisco
Career Start Year 1999
Number of shared co-authors 0
Mathew J Garnett
Wellcome Sanger Institute
Career Start Year 1998
Number of shared co-authors 2
Nhu-An Pham
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1998
Number of shared co-authors 0
Collin M Blakely
University of California san francisco
Career Start Year 1998
Number of shared co-authors 3
John D Gordan
Quantitative Biosciences Institute (QBI), University of California San Francisco
Career Start Year 1996
Number of shared co-authors 1
Krister Wennerberg
University of Copenhagen
Career Start Year 1994
Number of shared co-authors 2
Andrei Goga
University of California San Francisco
Career Start Year 1993
Number of shared co-authors 1
Ultan McDermott
Wellcome Sanger Institute
Career Start Year 1993
Number of shared co-authors 2
Levi A Garraway
Broad Institute of Harvard and MIT
Career Start Year 1991
Number of shared co-authors 3
Ben Ho Park
Vanderbilt University Medical Center
Career Start Year 1990
Number of shared co-authors 0
Lori S Hart
Children's Hospital of Philadelphia, USA. [2] Center for Childhood Cancer Research
Career Start Year 1987
Number of shared co-authors 0
Daniel S Peeper
Netherlands Cancer Institute
Career Start Year 1987
Number of shared co-authors 0

Collaborators

Kris C Wood
Duke University
Co-authored papers 13
Peter S Winter
Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School
Co-authored papers 7
Kevin H Lin
Duke University
Co-authored papers 5
Merve Cakir
Quantitative Biosciences Institute (QBI), University of California san francisco
Co-authored papers 5
Lorin Crawford
Center for Computational Molecular Biology, Brown University
Co-authored papers 4
Donald P McDonnell
Co-authored papers 4
Ashutosh Chilkoti
Duke University
Co-authored papers 3
Katherine R Singleton
Duke University
Co-authored papers 3
Yeong-Ran Ahn
Duke University
Co-authored papers 2
Alexandre Puissant
Universite de Paris, INSERM, CNRS
Co-authored papers 2
Terry Hyslop
Co-authored papers 2
Jason W Locasale
Duke University
Co-authored papers 2
Abigail Xie
Duke University
Co-authored papers 2
David M Sabatini
Whitehead Institute for Biomedical Research and Massachusetts Institute of Technology
Co-authored papers 1
E Alejandro Sweet-Cordero
University of California San Francisco
Co-authored papers 1
Monte M Winslow
Stanford University School of Medicine
Co-authored papers 1
Reinaldo Dal Bello
Universite Paris Cite, INSERM, CNRS
Co-authored papers 1
Xinghai Li
Duke University
Co-authored papers 1
Bryann Pardieu
Universite de Paris, INSERM, CNRS
Co-authored papers 1
Christina Curtis
Stanford University School of Medicine
Co-authored papers 1
Peter K Jackson
Stanford University School of Medicine, Center for Clinical Sciences Research
Co-authored papers 1
Andrew J Gentles
Stanford Center for Biomedical Informatics Research, Stanford University
Co-authored papers 1
Christopher F Bassil
Duke University School of Medicine Durham
Co-authored papers 1
Jennifer A Wargo
Co-authored papers 1
Raphael Itzykson
Universite Paris Cite, INSERM, CNRS
Co-authored papers 1
Jacob P Hoj
Duke University
Co-authored papers 1
Lawrence N Kwong
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
Raiyan T Sobhan
Duke University
Co-authored papers 1
Michael C Bassik
Stanford University Medical Center
Co-authored papers 1
Patrick Auberger
Universite Cote d'Azur, INSERM U5
Co-authored papers 1
Release 1.2